Olaratumab Intravenous and Pramipexole Dihydrochloride

• Generic Name: olaratumab
• Dosage Forms: n.a.
• Other Brand Names: Lartruvo

Olaratumab injection is used in combination with doxorubicin to treat soft tissue sarcoma (STS) in patients who cannot be cured with radiation therapy or surgery, and need to be treated with an anthracycline-containing regimen. Olaratumab interferes with the growth of tumor, which are eventually destroyed by the body.

Olaratumab is to be given only by or under the direct supervision of your doctor.

• Generic Name: pramipexole
• Dosage Forms: n.a.
• Other Brand Names: Mirapex, Mirapex ER

Symptomatic management of idiopathic parkinsonian syndrome.

Used as an adjunct to levodopa for the symptomatic management of parkinsonian syndrome in patients with advanced disease.

Also used as monotherapy for the initial symptomatic management of parkinsonian syndrome. Most clinicians would use levodopa for initial therapy in individuals >70 years of age (less likely than younger individuals to develop levodopa-related motor complications and because of concerns about cognitive dysfunction), in patients with cognitive impairment, and in those with severe disease. A dopamine receptor agonist may be preferred for initial therapy in patients ≤70 years of age.

Symptomatic management of moderate-to-severe primary restless legs syndrome (Ekbom syndrome).